Management of hypertensive crises: The scientific basis for treatment decisions

American Journal of Hypertension

Volumn 14, Issue 11 I, 2001, Pages 1154-1167

  Blumenfeld, Jon D ^a,b   Laragh, John H ^a  

^a WEILL CORNELL MEDICAL COLLEGE   (United States)

^b ROGOSIN INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA 1 ADRENERGIC RECEPTOR BLOCKING AGENT; BETA 1 ADRENERGIC RECEPTOR BLOCKING AGENT; CAPTOPRIL; CARVEDILOL; CLONIDINE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; DOXAZOSIN; ENALAPRILAT; ESMOLOL; FUROSEMIDE; GUANFACINE; LABETALOL; METOPROLOL; NITROPRUSSIDE SODIUM; PHENTOLAMINE; PRAZOSIN; TERAZOSIN;

ACUTE HEART INFARCTION; ALGORITHM; DISEASE ASSOCIATION; DRUG EFFICACY; DRUG SAFETY; HUMAN; HYPERTENSION; MEDICAL DECISION MAKING; PATHOGENESIS; PREECLAMPSIA; PREVALENCE; PRIORITY JOURNAL; REVIEW; STROKE; TREATMENT INDICATION; TREATMENT PLANNING;

EID: 0034755027     PISSN: 08957061     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0895-7061(01)02245-2     Document Type: Article

References (81)

1. Hypertensive emergency: Case criteria, socio-demographic profile, and previous care of 100 cases
2. Management of hypertensive crises
3. Should a moratorium be placed on sublingualnifedipine capsules given for hypertensive emergencies and pseudoemergencies
4. The sixth report of the joint national committee on prevention, detection and treatment of high blood pressure
5. Hypertensive urgencies and emergencies: Prevalence and clinical presentation
6. Vasoconstriction-volume analysis for understanding and treating hypertension: The use of renin and aldosterone profiles
7. The vasoconstriction-volume spectrum in normotension and in the pathogenesis of hypertension
8. Laragh lessons for treating hypertension: Lesson XV Poisseuille's Law via renin system behavior creates the volume vasoconstriction equation that supports all normotension or hypertension
9. The renin-angiotensin-aldosterone system and the renal regulation of sodium and potassium and blood pressure homeostasis
10. Electrolyte metabolism and aldosterone secretion in benign and malignant hypertension
11. Acute and chronic treatment of severe and malignant hypertension with the oral angiotensin-converting enzyme inhibitor captopril
12. Hypertensive emergencies
13. Laragh's lessons in pathophysiology for treating hypertension: Lessons XVI-XVIII, renin testing identifies two types of hypertension sodium volume V mediated (PRA <0.65) and renin R mediated (PRA >0.65) each correctly treated with anti-V or anti-R drugs, respectively
14. Prevalence of renovascular hypertension in patients with grade III or IV hypertensive retinopathy
15. Blood pressure after stroke
16. Acute hypertension after stroke: The scientific basis for treatment decisions
17. Autoregulation of cerebral blood flow in hypertensive patients: The modifying influence of prolonged antihypertensive treatment on the tolerance to acute, drug-induced hypotension
18. Treatment of hypertensive crisis
19. Emergency room management of hypertensive urgencies and emergencies
20. Local cerebral blood flow and vascular reactivity in a chronic stable stroke in baboons
21. Hypertension and its treatment in the NINDS rt-PA stroke trial
22. A randomized, double-blind, placebo-controlled trial of nimodipine in acute ischemic hemispheric stroke
23. Should hypertension be treated after acute stroke?: A randomized controlled trial using single photon emission computed tomography
24. Chronic treatment with the angiotensin I converting enzyme inhibitor, perindopril, restores the lower limit of autoregulation of cerebral blood flow in the awake renovascular hypertensive rat
25. Antihypertensive therapy in the elderly. Effects on blood pressure and cerebral blood flow
26. Management of hypertension in acute intracerebral hemorrhage
27. Calcium antagonists in patients with aneursymal subarachnoid hemorrhage: A systematic review
28. Haemodynamic effects of intravenous nimodipine following aneurysmal subarachnois hemorrhage: Implications for monitoring
29. Hypotensive effect of nimodipine during treatment for aneurysmal subarachnoid hemorrhage
30. Treatment of systemic hypertension and intracranial hypertension in cases of brain hemorrhage
31. A randomized controlled trial of high-dose intravenous nicardipine in aneurysmal subarachnoid hemorrhage: A report of the Cooperative Aneurysm study
32. Malignant hypertension: Mechanisms and management
33. Antihypertensive action of propranolol: Specific anti-renin responses in high and normal renin forms of essential, renal, renovascular and malignant hypetension
34. Converting enzyme inhibition in hypertensive emergencies
35. Clinical evaluation of different doses of intravenous enalaprilat in patients with hypertensive crises
36. The effect of beta-adrenergic receptor blocking drugs on cerebral blood flow
37. Aortic dissection
38. Treatment of dissecting aneurysms of the aorta without surgery
39. Sodium nitroprusside: Twenty years and counting
40. Nitroprusside and aortic dissecting aneurysm
41. Resistance to sodium nitroprusside in hypertensive patients
42. Differential hemodynamic and sympathoadrenal effects of sodium nitroprusside and hydralazine in hypertensive subjects
43. Captopril reduces the dose requirement for sodium nitroprusside-induced hypotension
44. Control of hypertension with nifedipine in the setting of aortic dissection
45. Relevance of intermittent increases in sympathetic activity for adverse outcome on short-acting calcium antagonists
46. Renovascular hypertension
47. Hormones regulating cardiovascular function in patients with severe congestive heart failure and their relation to mortality
48. Two-year time course and significance of neurohumoral activation in survival and ventricular enlargement (SAVE) study
49. Efficacy of captopril in low renin congestive heart failure: Importance of sustained reactive hyperreninemia in distinguishing responders from nonresponders
50. Preservation of glomerular filtration rate in human heart failure by activation of the renin-angiotensin system
51. Sodium and water balance in chronic congestive heart failure
52. Pathogenesis of sodium and water retention in high-output and low-output cardiac failure, nephrotic syndrome, cirrhosis, and pregnancy (1)
53. Pathogenesis of sodium and water retention in high-output and low-output cardiac failure, nephrotic syndrome, cirrhosis, and pregnancy (2)
54. Plasma norepinephrine, plasma renin activity, and congestive heart failure
55. Indications for ACE inhibitors in the early treatment of acute myocardial infarction: Systematic overview of the individual data from 100,000 patients in randomized trials
56. Effort of losartan compared with captopril on mortality in patients with symptomatic heart failure: Randomised trial - The losartan heart failure survival study ELITE II
57. Randomized trial of losartan versus captopril in patients over 65 with heart failure (Evaluation of Losartan in the Elderly Study, ELITE)
58. The effect of spironolactone on morbidity and mortality in patients with severe heart failure
59. Spironolactone in congestive heart failure refactory to high dose loop diuretics and low dose angiotesin converting enzyme inhibitor
60. Plasma renin activity in the emergency department and its independent association with acute myocardial infarction
61. Effect of captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction. Results of the survival and ventricular enlargement trial
62. Beta-adrenergic receptor blockade as a therapeutic approach for suppressing the renin-angiotensin-aldosterone system in normotensive and hypertensive subjects
63. Effect of beta-blockade on mortality among high-risk and low risk patients after myocardial infarction
64. Comparison between the effects of nitroprusside and nitroglycerin on ischemic injury during acute myocardial infarction
65. Review of calcium antagonist trials in acute myocardial infarction
66. Hemorrhagic potential of combined diltiazem and recombinant tissue-type plasminogen activator administration
67. Nimodipine neuroprotection in cardiac valve replacement: Report of an early terminated trial
68. Surgical bleeding and calcium antagonists
69. Cardiovascular complications of cocaine use
70. Cocaine-induced myocardial ischemia and infarction: Pathophysiology, recognition, and management
71. Autonomic mechanisms in the acute cardiovascular effects of cocaine in conscious rats
72. Report of the National High Blood Pressure Education Program Working Group on High Blood Pressure in Pregnancy
73. Magnesium sulfate therapy in preeclampsia and eclampsia
74. Angiotensin-converting enzyme inhibitor fetopathy
75. Final report of study on hypertension during pregnancy: The effects of specific treatment in the growth and development of the children
76. Nitroprusside in preeclampsia. Circulatory distress and paradoxical bradycardia
77. Renin system analysis: A rational method for the diagnosis and treatment of the individual patient with hypertension
78. Acute hypotensive response to post-synaptic alpha-blockade with prazosin in low and normal renin hypertension
79. Oral labetalol versus oral clonidine in the emergency treatment of severe hypertension